Fluidigm Corp. (FLDM)

5.59
0.35 6.70
NASDAQ : Health Technology
Prev Close 5.24
Open 5.26
Day Low/High 5.26 / 5.67
52 Wk Low/High 2.52 / 8.38
Volume 125.13K
Avg Volume 157.90K
Exchange NASDAQ
Shares Outstanding 38.92M
Market Cap 214.82M
EPS -1.80
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Fluidigm is Now Oversold (FLDM)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Commit To Purchase Fluidigm At $5, Earn 18.6% Annualized Using Options

Commit To Purchase Fluidigm At $5, Earn 18.6% Annualized Using Options

Investors considering a purchase of Fluidigm Corp shares, but cautious about paying the going market price of $6.90/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the August put at the $5 strike, which has a bid at the time of this writing of 40 cents.

Commit To Purchase Fluidigm Corp At $5, Earn 15.8% Annualized Using Options

Commit To Purchase Fluidigm Corp At $5, Earn 15.8% Annualized Using Options

Investors considering a purchase of Fluidigm Corp stock, but tentative about paying the going market price of $7.09/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the August put at the $5 strike, which has a bid at the time of this writing of 40 cents.

Fluidigm Announces Agreement With The University Of Zurich To Distribute HistoCAT For Multiparameter Imaging Mass Cytometry Data Analysis

Fluidigm Announces Agreement With The University Of Zurich To Distribute HistoCAT For Multiparameter Imaging Mass Cytometry Data Analysis

Fluidigm to distribute histoCAT™, the first multiparameter Imaging Mass Cytometry™ software that combines leading-edge image and cytometry analysis tailored to highly multiplexed imaging data in a simple and easy-to-use format.

Fluidigm Introduces Imaging Mass Cytometry System For Highly Multiplexed Protein Detection In Tissues

Fluidigm Introduces Imaging Mass Cytometry System For Highly Multiplexed Protein Detection In Tissues

The Hyperion™ Imaging System provides translational researchers with an unprecedented view of complex cellular phenotypes and their relationships in the tissue microenvironment.

Short Interest Expands By 10.6% For FLDM

Short Interest Expands By 10.6% For FLDM

The most recent short interest data has been released for the 08/31/2017 settlement date, which shows a 301,872 share increase in total short interest for Fluidigm Corp , to 3,142,831, an increase of 10.63% since 08/15/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

FLDM: Insiders vs. Shorts

FLDM: Insiders vs. Shorts

The most recent short interest data was recently released for the 07/14/2017 settlement date, and Fluidigm Corp is one of the most shorted stocks of the Russell 3000, based on 19.41 "days to cover" versus the median component at 6.16. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

Fluidigm Introduces Immuno-Oncology Gene Expression Assay For Translational And Clinical Research

Fluidigm Introduces Immuno-Oncology Gene Expression Assay For Translational And Clinical Research

Advanta Immuno-Oncology Gene Expression Assay enables efficient screening of 170 highly informative genes involved in human checkpoint therapeutic response

Fluidigm Stock Sees Short Interest Move 13.7% Lower

The most recent short interest data has been released for the 06/15/2017 settlement date, which shows a 355,914 share decrease in total short interest for Fluidigm Corp , to 2,244,445, a decrease of 13.69% since 05/31/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

TheStreet Quant Rating: D (Sell)